Table 6.

Correlation analysis between miR-155 gene expression and SOCS1, TAB2, and Foxp3 in cachectic pancreatic or NSCL cancer patients (Spearman’s correlation).

	miR-155 (FC)	SOCS1 (ng/ml)	TAB2 (ng/ml)
Cachectic pancreatic cancer patients
miR-155 (FC)
SOCS1 (ng/ml)	0.17 p = 0.3
TAB2 (ng/ml)	0.002 p = 0.9	−0.17 p = 0.2
Foxp3 (ng/ml)	0.1 p = 0.56	0.69 p = 0.001***	0.08 p = 0.4
Cachectic NSCL cancer patients
miR-155 (FC)
SOCS1 (ng/ml)	−0.3 p = 0.2
TAB2 (ng/ml)	−0.4 p = 0.09	−0.2 p = 0.1
Foxp3 (ng/ml)	−0.2 p = 0.3	−0.2 p = 0.6	0.08 p = 0.4

Data are given as r. Statistical analysis was carried out using Spearman’s correlation analysis; p ≤ 0.05.

FC, fold change; Foxp3, forkhead box P3; miR-155, microRNA-155; n, number; r, Spearman’s correlation coefficient; SOCS1, suppressor of cytokine signaling 1; TAB2, TAK1-associated Binding Protein 2; NSCL, non-small cell lung.

***Significant difference at p ≤ 0.001.